Botanical species · safety record

Artemisia apiacea

The EFSA Compendium of Botanicals holds 10 constituent measurements and 1 adverse-effect record for Artemisia apiacea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Artemisia apiacea Hance

10Constituent measurements

1Safety records

8Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Artemicapin c	Live plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Coumarins	Flowering top	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Daphnetin dimethyl ether	Flowering top	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Herniarin	Flowering top	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Scopoletin	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
1,8-cineole	Unspecified	Essential oil	7 Percent	GC-MS	No resolvable identifier
1,8-cineole	Unspecified	—	—	Chromatographic tests	No resolvable identifier
Alpha-thujone	Unspecified	—	—	Chromatographic tests	No resolvable identifier
Artemisia ketone	Unspecified	—	—	Chromatographic tests	No resolvable identifier
Artemisinin	Unspecified	—	—	—	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Live plants	Solvent extraction	—	In vitro	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Shimomura, H., Sashida, Y., Ohshima, Y. The Chemical Components of Artemisia apiacea Hance. II. More Coumarins from the Flower Heads. Chemical and Pharmaceutical Bulletin, 1980, vol. 28, no. 1, p. 347-348. DOI
SHIMOMURA, H., SASHIDA, Y., OHSHIMA, Y. CHEMICAL-COMPONENTS OF ARTEMISIA-APIACEA .1. COUMARINS FROM ARTEMISIA-APIACEA. PHYTOCHEMISTRY, 1979, vol. 18, no. 10, p. 1761-1762. DOI
Tu, Youyou. Artemisinin-A Gift from Traditional Chinese Medicine to the World (Nobel Lecture).. Angewandte chemie, international edition, 2016, vol. 55, no. 35, p. 10210-10226.
Kim, KS., Lee, S., Shin, JS., Shim, SH., Kim, BK. Arterninin, a new coumarin from Artemisia apiacea. FITOTERAPIA, 2002, vol. 73, no. 3, p. 266-268. DOI
Zhao, Lijuan., Xin, Guang., Zhang, Jieli. Volatile constituents of Artemisia apiacea Hance from Lulong Area in Hebei Province by gas chromatography-mass spectrometry.. Shizhen guoyi guoyao, 2006, vol. 17, no. 9, p. 1691-1692.
Yano, Katsumi. Mono- and sesqui-terpenes of the essential oils from Artemisia japonica and Artemisia apiacea.. Flavour industry, 1970, vol. 1, no. 5, p. 328-30.
Nurul Islam, Md., Jung, Hyun Ah., Sohn, Hee Sook., Kim, Hye Mi., Choi, Jae Sue. Potent alpha-glucosidase and protein tyrosine phosphatase 1B inhibitors from Artemisia capillaris.. Archives of Pharmacal Research, 2013, vol. 36, no. 5, p. 542-552. DOI
Lee, S., Kim, KS., Jang, JM., Park, Y., Kim, YB., Kim, BK. Phytochemical constituents from the herba of Artemisia apiacea. ARCHIVES OF PHARMACAL RESEARCH, 2002, vol. 25, no. 3, p. 285-288. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature